Federal regulators Monday ordered makers of some duodenoscopes to conduct post-market research on how disinfecting those devices works in medical settings. The move is in response to several recent outbreaks of antibiotic-resistant infections due to the scopes.
Federal regulators will begin destroying some medications that can't be imported into the U.S. because of quality concerns. The FDA says the new process will allow them to focus its limited resources.
Women receive significantly fewer aggressive treatments after a heart attack than men despite the fact that a greater percentage of women die from the events. Researchers say gender differences will play a greater role as healthcare moves toward an era of personalized or precision medicine.
Madison, N.J.-based Quest Diagnostics is teaming up with Inovalon, a Bowie, Md.-based analytics software provider, to launch a patient-specific data service.
Backscatter machines previously used in U.S. airports to check passengers for potential threats don't expose passengers to too much radiation, according to a report released Tuesday. The 148-page report comes as the Transportation Security Administration considers a second-generation model that...
A Pittsburgh-area medical system is re-opening its organ transplant program, six days after closing it because of concerns that mold contributed to the deaths of three transplant patients who had fungal infections.
Despite its title, “Improving Diagnosis in Health Care,” you have to dig deep into the Institute of Medicine's first-ever report on the problem of misdiagnosed patients to find proposals that will have an immediate impact on the problem.
On a recent getaway, some big fish from the healthcare safety and quality movement demonstrated that improving outcomes isn't their only talent.
During a Food and Drug Administration hearing Thursday to scrutinize the safety and efficacy of the Essure female contraceptive, Essure's maker, Bayer, revealed it had received more than 17,000 adverse-event reports from women around the globe.
The CMS Innovation Center is beefing up reporting requirements in a revived Partnership for Patients program whose initial three-year effort fell short of expectations in reducing hospital-acquired conditions that cause patient harm.
A panel of independent experts Thursday told the U.S. Food and Drug Administration that not enough research was done to prove the safety of a permanent female sterilization device it approved 13 years ago, and that it should limit its use. Activists wanted Essure pulled from the market.
A pharmaceutical company's move to raise the price of a generic drug by more than 5,000% has some pointing to the lack of regulation over the market. Experts say companies are acquiring generics to drive up their prices and can do that because there aren't many competitors.